Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial-Reference-Cited by-同舟云学术

Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: a follow-up of the Eastern Cooperative Oncology Group E3A98 trial

Published:2009-09-14 Issue:5 Volume:147 Page:677-680
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Gertz Morie A.,Abonour Rafat,Heffner Leonard T.,Greipp Philip R.,Uno Hajime,Rajkumar S. V.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2009.07892.x/fullpdf

Reference12 articles.

1. Prognostic factors and response to fludarabine therapy in Waldenstrom’s macroglobulinemia: an update of a US intergroup trial (SWOG S9003);Dhodapkar;Seminars in Oncology,2003

2. Long-term survival in Waldenstrom macroglobulinemia: 10-year follow-up of Southwest Oncology Group-directed intergroup trial S9003;Dhodapkar;Blood,2009

3. Treatment of Waldenstrom’s macroglobulinemia with rituximab: prognostic factors for response and progression;Dimopoulos;Leukemia and Lymphoma,2004

4. Waldenström macroglobulinaemia;Fonseca;British Journal of Haematology,2007

5. Treatment recommendations in Waldenstrom’s macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom’s Macroglobulinemia;Gertz;Seminars in Oncology,2003

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal residual disease status improved the response evaluation in patients with Waldenström’s macroglobulinemia;Frontiers in Immunology;2023-05-10

2. Current approach to Waldenström Macroglobulinemia;Cancer Treatment and Research Communications;2022

3. Post‐relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation;Hematological Oncology;2021-11-20

4. How to Sequence Therapies in Waldenström Macroglobulinemia;Current Treatment Options in Oncology;2021-08-23

5. Waldenström macroglobulinemia: 2021 update on diagnosis, risk stratification, and management;American Journal of Hematology;2021-01-18